Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.
about
Asymmetric dimethyarginine as marker and mediator in ischemic strokeRight ventricular afterload and the role of nitric oxide metabolism in left-sided heart failureGenetic Architecture of Atherosclerosis in Mice: A Systems Genetics Analysis of Common Inbred StrainsAsymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studiesDysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemiaIncreased asymmetric dimethylarginine in severe falciparum malaria: association with impaired nitric oxide bioavailability and fatal outcomeNitric oxide synthetic pathway in patients with microvascular angina and its relations with oxidative stressPlasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension.Optimization of the separation of NDA-derivatized methylarginines by capillary and microchip electrophoresis.Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry.Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipientsMetabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function.Simultaneous determination of 6 L-arginine metabolites in human and mouse plasma by using hydrophilic-interaction chromatography and electrospray tandem mass spectrometry.Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort.Arsenic induces structural and compositional colonic microbiome change and promotes host nitrogen and amino acid metabolism.Nitric oxide-mediated coronary flow regulation in patients with coronary artery disease: recent advances.Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective StudiesSymmetric Dimethylarginine Is Not Associated with Cumulative Inflammatory Load or Classical Cardiovascular Risk Factors in Rheumatoid Arthritis: A 6-Year Follow-Up Study.Endothelial injury in rheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammation.A method for large-scale identification of protein arginine methylationPulmonary hypertension associated with advanced systolic heart failure: dysregulated arginine metabolism and importance of compensatory dimethylarginine dimethylaminohydrolase-1.A robust distribution-free test for genetic association studies of quantitative traits.Genome-wide association study of L-arginine and dimethylarginines reveals novel metabolic pathway for symmetric dimethylarginine.Asymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study.Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks.Heat-assisted extraction for the determination of methylarginines in serum by CE.Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study.Inhibition of autophagy with bafilomycin and chloroquine decreases mitochondrial quality and bioenergetic function in primary neurons.Asymmetric dimethylarginine and all-cause mortality: a systematic review and meta-analysis.The role of metabolites and metabolomics in clinically applicable biomarkers of disease.Integration of metabolomics in heart disease and diabetes research: current achievements and future outlook.Translating metabolomics to cardiovascular biomarkers.Progress and challenges in predicting protein methylation sites.Novel Risk Stratification Assays for Acute Coronary Syndrome.The story of protein arginine methylation: characterization, regulation, and function.Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study.Accurate in silico prediction of species-specific methylation sites based on information gain feature optimization.Genetic variations in the alanine-glyoxylate aminotransferase 2 (AGXT2) gene and dimethylarginines levels in rheumatoid arthritis.In vivo microvascular and macrovascular endothelial function is not associated with circulating dimethylarginines in patients with rheumatoid arthritis: a prospective analysis of the DRACCO cohort.Serum homocysteine, asymmetric dimethyl arginine (ADMA) and other arginine-NO pathway metabolite levels in patients with psoriasis.
P2860
Q26864318-E03D65EF-6E17-4B78-9671-6123ECD9FD3EQ27022359-6561BDD5-AE56-4317-AFC0-1F001C9C42B8Q27309881-96B87CB9-3FA4-4E9D-A758-60F7FAF3FE0DQ28087272-142E391E-4CC9-4BB1-981C-BE636C0B5356Q28395387-0A4E27A4-EC25-41E7-8E8E-AACAF2DA76A6Q33565412-C0D76F40-614F-4619-9519-9988D4E439B7Q33594387-7B9FAA22-AB95-49A0-A68C-1EFE2D11DBE1Q34118474-61F37F3E-69B8-40FC-B2E1-F6B97DD1BF50Q34167247-4A07D3D0-1690-4C38-B8E9-D28438CF52D0Q34202445-0CCA579B-1E0C-4A45-B004-2F209BA46AB4Q34556614-C1AA3E2E-B884-4639-9C16-05668B962F27Q35219088-BC98D4C6-F6FC-4A10-9281-611C162ED817Q35422140-1AFF86A6-FC0A-45A5-B297-CF6661F8094FQ35607229-63186118-6939-49D1-86B1-AD8BD8E33CC3Q35830809-ABFF5EBF-A386-44A4-BEC9-5CFBA9DD3826Q35902581-E7CFC8FC-0C71-4348-A59B-69AD98BDDBD2Q36182184-F4166488-FF98-4223-9193-D4174CD759BDQ36205262-79DA9480-C450-4BDA-9B11-37EB60751F4BQ36276126-9448FB70-5CE5-4780-9A83-F4CC6D46E10AQ36386994-6BEAC353-D7E4-403C-808B-33CB6120C318Q36590608-C5150E73-1A78-460A-AFD8-350674EEEA91Q36677707-01F8DCB3-9FB8-49C2-9BD7-41A03FDDE86EQ36701882-F0136851-17E9-4A77-A513-2F6196D10D31Q36846899-41D1DE9C-AACB-4216-97E2-1CAC54A4D307Q37094822-3B2056CF-213F-49C2-B5CF-5BCB60D022CAQ37096680-1777B4EA-4F6B-4E7C-808E-9326D3BAA796Q37365823-A4C76A04-4E2A-4539-A808-E3B5222611B7Q37442973-01642915-7C07-4469-B2E8-E3FA41383D6CQ37704715-F47682EB-283A-4880-ACD3-E66983E3A4B8Q37800811-5008CD3D-445F-48A2-8DFC-E33F510B999BQ37943853-4C80A22F-10C0-499E-AF73-D3946B212F07Q38028672-268CE05B-AC3E-4B34-90CE-7B548D4F935DQ38529273-25683996-1B43-45C0-ABC4-6CF8CE7E79F9Q38666324-43BF7D25-7B44-4534-9DC4-B379ACBCA8D1Q39064771-3744E8EF-ED7C-497B-8F1B-18782FDB55EBQ39535124-79C059BE-453B-40D8-B134-A52DE94DEB62Q39646851-8E7B59B9-C9C4-4F0C-AB6D-3FCA4B0D386BQ40267428-6923A29F-86F2-4EBF-845B-767E982ACC70Q40760252-F93AED93-25ED-46B9-A1CA-26F716614C01Q41363722-F6E00D7A-936B-45B8-B53D-23EC6256CCE7
P2860
Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeted metabolomic evaluatio ...... ric oxide synthase inhibition.
@en
Targeted metabolomic evaluatio ...... ric oxide synthase inhibition.
@nl
type
label
Targeted metabolomic evaluatio ...... ric oxide synthase inhibition.
@en
Targeted metabolomic evaluatio ...... ric oxide synthase inhibition.
@nl
prefLabel
Targeted metabolomic evaluatio ...... ric oxide synthase inhibition.
@en
Targeted metabolomic evaluatio ...... ric oxide synthase inhibition.
@nl
P2093
P2860
P1476
Targeted metabolomic evaluatio ...... ric oxide synthase inhibition.
@en
P2093
Leslie Cho
Stanley L Hazen
W H Wilson Tang
Zeneng Wang
P2860
P304
P356
10.1161/ATVBAHA.109.185645
P407
P577
2009-06-18T00:00:00Z